KYLYS AESTHETICS offers a biocompatible hyaluronan-based and thermosensitive dermal filler (Medical Device Class III) that has the ability to form microgel structures in the tissue, resulting in a long-lasting effect and no migration from the injection site. Our patented technology allows for injection with an ultra-thin 34G needle, resulting in greater precision, less pain for the patient, and fewer hematomas. With our cutting-edge technology and commitment to research and development, we aim to revolutionize the market of skin filling.
We recently completed all preclinical testing, including biocompatibility, and are now preparing for our 1st pilot clinical trial scheduled for August 2024. With the initial clinical data in hand, we will initiate our Series A with the right partner.
Location: Switzerland, Geneva, Arare
Investors 2
| Date | Name | Website |
| 05.03.2024 | Venture Ki... | venturekic... |
| 25.03.2024 | VentureLab | venturelab... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 27.03.2024 | Ten startups on a business voyage in Boston | Selected from over 70 applications by a jury of investors and biotech experts, the ten startups sel... | startuptic... |
| 16.05.2023 | FIF supports Fluosphera, Kylys Aesthetics and Consulto | startuptic... | |
| 09.11.2021 | The AIT India digital edition kicks off | startuptic... | |
| 02.11.2021 | Startups recycling composites into reusable fibers, developi... | Composite Recycling: Recycling Composites Into Reusable Fibers Every year in Europe, around 100000 b... | venturekic... |
| - | KYLYS | “KYLYS – Biomolecules now, for your future” | fastfounde... |